EVERSANA, a US-based provider of commercial services to the life sciences industry, has announced the expansion of its pharmacovigilance and drug safety offering.
The company has signed an agreement with Oracle Argus Cloud, a part of the Oracle Safety Cloud, to provide comprehensive features and functionalities.
Oracle Argus Cloud will enable AI-powered automation, workflow optimisation, and conditional touchless processing to manage increasing caseloads and changing regulations.
The company said that several pharmacovigilance customers have moved to the platform, and all future customers can benefit from the advanced drug safety management system.
EVERSANA has been an Oracle Partner Network Member since 2023 and is now promoted by Oracle to global customers for pharmacovigilance and implementation services.
Both events strengthen its drug safety management capabilities and its role in commercialization success, said the commercial services provider.
EVERSANA CEO Jim Lang said: “We believe that pharmacovigilance services across the life sciences industry are powered by innovation and transformational thinking.
“Together with Oracle’s leading systems, we are doing just this, combining our experience and operational excellence with best-in-class systems to drive better outcomes and put patient safety first.”
In addition to expanding its technology capabilities with Oracle, EVERSANA has also rapidly expanded its global medical information contact centre capabilities.
The company is currently offering multi-language and around-the-clock support across four regional hubs including North America, Europe, India, and Japan.
The regional hubs will have trained experts to answer calls from clinicians, patients, and caregivers in their native language to provide the latest information on therapy.
Also, the regional hubs allow users to report any adverse effects or product complaints.
Recently, EVERSANA announced the continued growth of its footprint with a new office in Berlin, Germany, the largest pharmaceutical market in Europe.
Lang added: “Today’s drug safety industry demands that service providers deliver critical medical information to doctors and patients in their region and at any time.
“Our investments in global experts top talent and transformational technology will help bring this commitment to life.”
